Your immune system is supposed to protect you. But sometimes it makes a mistake. It produces antibodies that attack healthy brain cells, causing seizures that don't respond to regular anti-seizure medications. This is autoimmune epilepsy — and recognizing it early can change everything.
Key Facts About Autoimmune Epilepsy
- Up to 20% of drug-resistant epilepsies may have an autoimmune cause
- Antibody testing can identify the specific immune attack
- Immunotherapy can control seizures when anti-seizure medications fail
- Early treatment leads to better outcomes
- Antibody panels are now available at major labs across India
What is Autoimmune Epilepsy?
In autoimmune epilepsy, your body's immune system produces antibodies that target proteins on the surface of brain cells (neurons). These proteins are important for normal brain signaling. When antibodies attack them, the brain becomes hyperexcitable — and seizures follow.
This is different from most epilepsies. In typical epilepsy, the seizures come from structural brain damage or genetic factors. In autoimmune epilepsy, the brain structure may look completely normal on MRI. The problem is at the molecular level.
When Should You Suspect Autoimmune Epilepsy?
Not every patient with seizures needs antibody testing. But certain patterns should raise suspicion:
- New-onset seizures that are immediately drug-resistant — medications that usually work don't help
- Seizures with psychiatric symptoms — confusion, personality changes, hallucinations alongside seizures
- Rapidly progressive course — going from normal to frequent seizures within days or weeks
- Memory problems — especially new difficulty forming memories
- Movement disorders with seizures — unusual facial movements (faciobrachial dystonic seizures)
- History of autoimmune disease — thyroid disorders, lupus, or other autoimmune conditions
- Ovarian teratoma in young women — strongly associated with anti-NMDA receptor encephalitis
Common Types of Autoimmune Epilepsy
Anti-NMDA Receptor Encephalitis
Who it affects: Young women (often 15-35 years)
Symptoms: Psychiatric symptoms first (psychosis, agitation), then seizures, movement disorders, decreased consciousness
Key clue: Often associated with ovarian teratoma
Treatment: Immunotherapy + tumor removal if present
Anti-LGI1 Encephalitis
Who it affects: Middle-aged to older adults (50-70 years)
Symptoms: Faciobrachial dystonic seizures (brief arm/face jerks), memory loss, low sodium levels
Key clue: Very brief seizures, often dozens per day
Treatment: Responds well to immunotherapy; anti-seizure medications alone often fail
Anti-CASPR2 Encephalitis
Who it affects: Older men predominantly
Symptoms: Seizures, peripheral nerve hyperexcitability (muscle twitching, cramps), sleep disturbance
Key clue: Combination of brain and nerve symptoms
Treatment: Immunotherapy; screen for thymoma
Anti-GAD65 Epilepsy
Who it affects: Women more than men; any age
Symptoms: Drug-resistant temporal lobe epilepsy, stiff person syndrome, cerebellar problems
Key clue: Very high GAD65 antibody levels (>10,000 IU/mL); may have Type 1 diabetes
Treatment: More difficult to treat; immunotherapy helps some patients
How is Autoimmune Epilepsy Diagnosed?
Diagnosis involves several steps:
- Clinical suspicion — recognizing the pattern of symptoms described above
- MRI brain — may show signal changes in the temporal lobes (but can be normal)
- EEG — often shows temporal lobe seizure activity or extreme delta brush pattern (in NMDA receptor encephalitis)
- CSF analysis — lumbar puncture may show inflammation (increased white cells, protein)
- Antibody testing — blood AND cerebrospinal fluid tested for specific antibodies
- Autoimmune encephalitis panel (serum): Available at major labs
- CSF antibody panel: Contact lab for current rates
- Individual antibodies (NMDA, LGI1): Pricing varies by lab
- Available at: SRL, Metropolis, Neuberg, and specialized neuro labs
Treatment: Immunotherapy for Seizures
The treatment for autoimmune epilepsy is fundamentally different from regular epilepsy. While anti-seizure medications may provide partial control, the real treatment targets the immune system.
First-Line Immunotherapy
- IV Methylprednisolone — high-dose steroids given over 3-5 days
- IV Immunoglobulin (IVIg) — pooled antibodies that modulate the immune response
- Plasma exchange (PLEX) — filters harmful antibodies from the blood
Second-Line Immunotherapy
If first-line treatment doesn't work fully:
- Rituximab — targets B-cells that produce the harmful antibodies
- Cyclophosphamide — stronger immunosuppression
- Mycophenolate or Azathioprine — for long-term maintenance
What About Anti-Seizure Medications?
Anti-seizure medications are still used alongside immunotherapy for seizure control. But here's the key difference: in autoimmune epilepsy, medications alone rarely achieve seizure freedom. Immunotherapy addresses the root cause.
Outcomes: What to Expect
The good news is that many patients with autoimmune epilepsy improve significantly with proper treatment:
- Anti-NMDA receptor encephalitis: About 80% of patients recover well with treatment (may take months)
- Anti-LGI1: Responds very well to immunotherapy; most patients achieve seizure freedom
- Anti-GAD65: More variable response; some patients improve, others remain drug-resistant
Early treatment is critical. The longer autoimmune inflammation continues unchecked, the more permanent damage it can cause.
Autoimmune Epilepsy in India
Awareness of autoimmune epilepsy is growing in India, but it's still underdiagnosed. Many patients spend years on anti-seizure medications before the autoimmune cause is identified. This is changing as more neurologists recognize the clinical patterns and antibody testing becomes more accessible.
At Gujarat Epilepsy & Neuro Clinic, we evaluate patients with drug-resistant epilepsy for autoimmune causes as part of our standard workup. Early identification means earlier treatment and better outcomes.